Haemonetics Return on Tangible Equity 2010-2023 | HAE
Current and historical return on tangible equity values for Haemonetics (HAE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Haemonetics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2023-12-31 | $0.13B | $-0.04B | 146.51% |
| 2023-09-30 | $0.13B | $0.18B | 124.88% |
| 2023-06-30 | $0.14B | $0.13B | 267.98% |
| 2023-03-31 | $0.12B | $0.08B | 621.62% |
| 2022-12-31 | $0.10B | $0.03B | -1280.00% |
| 2022-09-30 | $0.09B | $-0.03B | -296.55% |
| 2022-06-30 | $0.07B | $0.00B | -140.21% |
| 2022-03-31 | $0.04B | $-0.03B | -51.92% |
| 2021-12-31 | $0.02B | $-0.06B | -22.38% |
| 2021-09-30 | $0.03B | $-0.11B | 376.47% |
| 2021-06-30 | $0.07B | $-0.14B | 55.67% |
| 2021-03-31 | $0.08B | $-0.10B | 37.04% |
| 2020-12-31 | $0.11B | $0.38B | 36.12% |
| 2020-09-30 | $0.11B | $0.33B | 39.67% |
| 2020-06-30 | $0.10B | $0.25B | 37.94% |
| 2020-03-31 | $0.08B | $0.24B | 30.29% |
| 2019-12-31 | $0.08B | $0.26B | 29.01% |
| 2019-09-30 | $0.07B | $0.26B | 23.76% |
| 2019-06-30 | $0.05B | $0.26B | 16.19% |
| 2019-03-31 | $0.06B | $0.33B | 17.05% |
| 2018-12-31 | $0.05B | $0.30B | 13.68% |
| 2018-09-30 | $0.02B | $0.35B | 5.62% |
| 2018-06-30 | $0.02B | $0.31B | 5.62% |
| 2018-03-31 | $0.05B | $0.38B | 10.97% |
| 2017-12-31 | $-0.02B | $0.45B | -4.48% |
| 2017-09-30 | $0.00B | $0.42B | 1.08% |
| 2017-06-30 | $0.00B | $0.39B | 1.19% |
| 2017-03-31 | $-0.03B | $0.35B | -8.62% |
| 2016-12-31 | $0.02B | $0.32B | 5.80% |
| 2016-09-30 | $-0.06B | $0.29B | -22.66% |
| 2016-06-30 | $-0.07B | $0.25B | -27.60% |
| 2016-03-31 | $-0.06B | $0.25B | -24.20% |
| 2015-12-31 | $-0.05B | $0.24B | -21.61% |
| 2015-09-30 | $0.03B | $0.21B | 11.34% |
| 2015-06-30 | $0.02B | $0.22B | 8.53% |
| 2015-03-31 | $0.02B | $0.25B | 6.84% |
| 2014-12-31 | $0.03B | $0.25B | 12.64% |
| 2014-09-30 | $0.03B | $0.23B | 13.14% |
| 2014-06-30 | $0.04B | $0.21B | 18.71% |
| 2014-03-31 | $0.04B | $0.23B | 18.06% |
| 2013-12-31 | $0.04B | $0.21B | 21.14% |
| 2013-09-30 | $0.03B | $0.18B | 18.55% |
| 2013-06-30 | $0.02B | $0.15B | 13.25% |
| 2013-03-31 | $0.04B | $0.17B | 15.12% |
| 2012-12-31 | $0.05B | $0.18B | 12.81% |
| 2012-09-30 | $0.05B | $0.15B | 12.37% |
| 2012-06-30 | $0.06B | $0.55B | 11.85% |
| 2012-03-31 | $0.07B | $0.52B | 13.58% |
| 2011-12-31 | $0.07B | $0.49B | 14.57% |
| 2011-09-30 | $0.07B | $0.46B | 15.43% |
| 2011-06-30 | $0.08B | $0.50B | 17.65% |
| 2011-03-31 | $0.08B | $0.47B | 19.31% |
| 2010-12-31 | $0.06B | $0.44B | 16.04% |
| 2010-09-30 | $0.06B | $0.39B | 15.64% |
| 2010-06-30 | $0.06B | $0.36B | 14.45% |
| 2010-03-31 | $0.06B | $0.38B | 13.90% |
| 2009-12-31 | $0.07B | $0.43B | 15.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.900B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |